Literature DB >> 21835661

Body composition in ambulatory patients with multiple sclerosis.

Chrissa Sioka1, Andreas Fotopoulos, Athanasia Georgiou, Stylianos Papakonstantinou, Sygliti-Henrietta Pelidou, Athanasios P Kyritsis, John A Kalef-Ezra.   

Abstract

The aim of this study was to compare between ambulatory patients with multiple sclerosis (MS) and control subjects, bone mineral density (BMD), and body composition, that is, percent of bone minerals (M%), fat (F%), and remaining substances (L%). Total body composition and BMD were measured by dual-energy X-ray absorptiometry in 68 patients with definite MS and Expanded Disability Status Scale (EDSS) score ≤ 6.5 (41 females and 27 males) and 114 control individuals (72 females and 42 males). The amount of F%, L%, M%, and BMD in the whole body, arms, and trunk was not statistically different between MS patients (males and females) and controls, except in the lower extremities of female patients where there was increased F% and reduced L% compared with controls. There were no correlations between F%, L%, M%, and BMD at any anatomic region with EDSS or the cumulative corticosteroid dose. The reduced L% in the lower extremities of female patients suggests a possible increased subsequent risk of osteoporosis in the legs. Brief steroid courses administered during disease exacerbations in ambulatory MS patients did not result in obvious adverse consequences. Copyright Â
© 2011 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21835661     DOI: 10.1016/j.jocd.2011.04.012

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  9 in total

Review 1.  Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.

Authors:  Faryal Mirza; Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2015-05-13       Impact factor: 6.664

Review 2.  Wellness and the Role of Comorbidities in Multiple Sclerosis.

Authors:  Brandon P Moss; Mary R Rensel; Carrie M Hersh
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

3.  Development and Cross-Validation of a Simple Model to Estimate Percent Body Fat in Persons with Multiple Sclerosis.

Authors:  Fabio Bertapelli; Stephanie L Silveira; Stamatis Agiovlasitis; Robert W Motl
Journal:  Int J MS Care       Date:  2021-01-12

4.  The Combinational Role of Vitamin D and Other Conditions in Multiple Sclerosis Patients.

Authors:  Chrissa Sioka
Journal:  Ethiop J Health Sci       Date:  2022-01

5.  Body composition in multiple sclerosis.

Authors:  Y Dionyssiotis
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

6.  Multiple sclerosis affects skeletal muscle characteristics.

Authors:  Inez Wens; Ulrik Dalgas; Frank Vandenabeele; Maartje Krekels; Lotte Grevendonk; Bert O Eijnde
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

7.  Muscle Quality of Knee Extensors Based on Several Types of Force in Multiple Sclerosis Patients with Varying Degrees of Disability.

Authors:  Kora Portilla-Cueto; Carlos Medina-Pérez; Ena Monserrat Romero-Pérez; Gabriel Núñez-Othón; Mario A Horta-Gim; José Antonio de Paz
Journal:  Medicina (Kaunas)       Date:  2022-02-19       Impact factor: 2.430

8.  Body composition differences between adults with multiple sclerosis and BMI-matched controls without MS.

Authors:  Brooks C Wingo; Hui-Ju Young; Robert W Motl
Journal:  Disabil Health J       Date:  2017-10-16       Impact factor: 4.615

9.  Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease.

Authors:  Solaleh Emamgholipour; Seyede Mahdieh Eshaghi; Arash Hossein-nezhad; Khadijeh Mirzaei; Zhila Maghbooli; Mohammad Ali Sahraian
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.